A SBIR Phase I contract was awarded to Ossium Health in July, 2020 for $157,465.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
A STTR Phase I contract was awarded to Ossium Health in September, 2021 for $248,452.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
A SBIR Phase II contract was awarded to Ossium Health in March, 2020 for $778,661.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
A SBIR Phase I contract was awarded to Ossium Health in March, 2018 for $224,961.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
A SBIR Phase II contract was awarded to Ossium Health in May, 2019 for $682,556.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
A STTR Phase I contract was awarded to Ossium Health in September, 2021 for $224,453.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
A SBIR Phase I contract was awarded to Ossium Health in August, 2020 for $299,998.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
A SBIR Phase I contract was awarded to Ossium Health in February, 2017 for $272,587.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to Ossium Health in July, 2017 for $239,080.0 USD from the U.S. Department of Health & Human Services.